Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster

Abstract Background Risk of cardiovascular events may increase after herpes zoster; therefore, American College of Rheumatology guidelines strongly recommend vaccination against herpes zoster in patients aged ≥ 18 years with rheumatic and musculoskeletal diseases taking immunosuppressive medications...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Jeffrey R. Curtis, Danielle M. Conrad, Whitney S. Krueger, Andrew P. Gara, Kevin L. Winthrop
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2025-05-01
Цуврал:	Arthritis Research & Therapy
Нөхцлүүд:	Arthritis Cardiovascular disease Herpes zoster Inflammatory disease Real-world studies Vaccines
Онлайн хандалт:	https://doi.org/10.1186/s13075-025-03565-0
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!